Proinflammatory cytokines, nutritional support, and the cachexia syndrome: interactions and therapeutic options.
about
Cancer cachexia--pathophysiology and managementRegulation of IGF-I function by proinflammatory cytokines: at the interface of immunology and endocrinologyFunctional overload attenuates plantaris atrophy in tumor-bearing ratsNovel role for tumor-induced expansion of myeloid-derived cells in cancer cachexiaThe effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer.Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases?Role of interleukin 1 and interleukin 1 receptor antagonist in the mediation of rheumatoid arthritis.Cancer cachexia, mechanism and treatmentThe role of myostatin in muscle wasting: an overviewAngiotensin II reduces food intake by altering orexigenic neuropeptide expression in the mouse hypothalamus.A polymorphism of the interleukin-1 beta gene influences survival in pancreatic cancer.The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer.The effect of deprivation and the systemic inflammatory response on outcome following curative resection for colorectal cancerHypothesis: solid tumours behave as systemic metabolic dictators.Marginal dietary zinc deprivation augments sepsis-induced alterations in skeletal muscle TNF-α but not protein synthesis.Non-surgical oncology - Guidelines on Parenteral Nutrition, Chapter 19Chemopreventive and Chemotherapeutic Effects of Fish Oil derived Omega-3 Polyunsaturated Fatty Acids on Colon Carcinogenesis.Prognostic Index for Survival in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Third-Generation Agents.Expression of the ZIP/SLC39A transporters in β-cells: a systematic review and integration of multiple datasets.Subclinical involvement of the liver is associated with prognosis in treatment naïve cancer patients.
P2860
Q24605567-B7E73BBE-71E6-4D24-AE9B-FFDF5CA04BEAQ28386983-90B1A1CC-3446-4FC7-986A-2B7FF51FEC2AQ33293233-550BE49E-5B8F-4DDB-9072-F60D669DF458Q33834933-26381916-8D02-4EE1-9D75-732F739250E2Q33874156-2443B8B9-896D-4A29-8A84-0A1F5392B821Q33890792-E03F8B0F-7FEF-4601-8A50-B8CFBD9F41B7Q34071325-3EC209CE-B3BA-4F23-9DD6-6DD236E66AB8Q34669440-A1DDD24B-F1EB-44C2-8B04-6ACF12279016Q35223987-2EAD0D14-2D4D-4012-B3FD-71D66C6BB0BFQ35762656-EF01E3C4-4D0A-4E82-9A59-1CDF95FCD1A4Q36621512-F1FEB074-1968-4F21-B89E-A686274DCD48Q36623998-779DC1F5-D1FB-419B-B296-CBE08B33C61CQ36648349-A8941548-EABA-42B0-942F-6312EC3283CAQ36942376-6E80D9E9-93D4-41C1-B32A-DE7ABED9315BQ37419009-424C8A00-17AF-478F-9B2B-2E5F6C5B9670Q37667893-E0FD6ECB-4315-48FC-B41C-059F2CCF82EDQ38645370-A478014C-8C49-4C93-A8AC-09C60C55AA4FQ38803727-8203F4AA-B599-4CCF-B127-DCACEB8236B4Q41278947-653EB299-5283-491F-A789-ABBA6117B4D6Q44600421-6C8CEA6D-58F8-4FB5-B4F6-ED1437FE6781
P2860
Proinflammatory cytokines, nutritional support, and the cachexia syndrome: interactions and therapeutic options.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Proinflammatory cytokines, nut ...... tions and therapeutic options.
@en
type
label
Proinflammatory cytokines, nut ...... tions and therapeutic options.
@en
prefLabel
Proinflammatory cytokines, nut ...... tions and therapeutic options.
@en
P1433
P1476
Proinflammatory cytokines, nut ...... tions and therapeutic options.
@en
P2093
Copeland EM 3rd
Moldawer LL
P304
P356
10.1002/(SICI)1097-0142(19970501)79:9<1828::AID-CNCR28>3.3.CO;2-D
P407
P577
1997-05-01T00:00:00Z